PRKAA1 and hepatocellular carcinoma: To study the link between AMPK activation and Kaempferol-induced actions in HCC cells, AMPKα1 shRNA and the dominant negative mutant AMPKα1 (dn-AMPKα1, T172A) [42] were applied to block AMPK activation.